Main outcome measures-Reported success rates of applications for training posts. Results-Comparison of the career patterns of women and men yielded no evidence of discrimination against women in competition for posts. In contrast, there were striking differences in career patterns between graduates of native European origin and those of ethnic minority origin. Graduates from ethnic minorities reported lower success rates and more difficulty in obtaining house officer posts, registrar posts, and places in vocational training schemes in general practice. Most of this discrimination seemed to occur at the stage of shortlisting for interview. Graduates from ethnic minorities were more likely than graduates of native European origin to have experienced spells of unemployment while seeking work. They were also more likely to have changed their original choice of career because of difficulty in obtaining suitable training posts or unfavourable career prospects.
Conclusions-Discrimination against ethnic minorities occurs in the competition for training posts among graduates from British medical schools. There was no evidence of discrimination against women graduates. Shortlisting procedures based on objective scoring systems may help to ensure equality of opportunity in future.
Introduction
Several lines of evidence suggest that discrimination against women and ethnic minorities occurs in British medicine. 2 Systematic discrimination has been recorded in the admissions procedure of at least one medical school,3 and analysis of the proportions of students at other medical schools who had nonEuropean names suggests that this was not an isolated instance.' The only available data on the career patterns of British trained doctors from ethnic minorities are from a survey of hospital doctors in two northern regions in 1980. 4 Among graduates from ethnic minorities there was a striking excess of difficulties related to obtaining training posts. These graduates were no more likely than others to choose oversubscribed specialties in which such difficulties would have been expected. It is unlikely that graduates from ethnic minorities were less well qualified than their native European counterparts as there is no evidence that medical school admission policies discriminate in favour of less able applicants from ethnic minorities, and there is considerable evidence that the opposite is the case. "' The strength and consistency of the associations found in this study leave little doubt that discrimination against British trained doctors of ethnic minority origin occurs in the competition for training posts.
Most of this discrimination seems to have occurred in the process of shortlisting applicants for senior house officer and registrar posts. Differences between native European and ethnic minority graduates in success rates at interview were much less clear cut. Discrimination at the shortlisting stage may have been based on non-European names, country of birth, and other clues to ethnic origin. The filling of posts by personal arrangement rather than open competition is another possible mechanism of discrimination. Implementing a formal system of grading applicants for senior house officer and registrar posts might help to ensure fair treatment. Monitoring the ethnic mix of doctors appointed in hospitals might also be useful in identifying sites where discrimination may be occurring. We understand that the Department of Health is preparing a draft circular on the implementation ofequal opportunities in recruitment and selection procedures for hospital doctors.
Survival rates in patients with paracetamol induced fulminant hepatic failure have improved in recent years, probably as a consequence of improvements in intensive liver care, though mortality still remains high (47% in our unit).' Many variables have been used to assess outcome in these patients,2 and coagulation studies have been established as prognostic indicators. 3 In an early study in our unit factor VII concentration was shown to provide a good indication of prognosis,4 and, later use of serial factor VII concentrations were shown to improve the predictive power of this test.5 Bernuau et al in Paris, using multivariate analysis, found that a reduced factor V concentration was the most sensitive prognostic indicator in patients with fulminant hepatitis B infection.6 Assay of individual clotting factors is not, however, a routine investigation in most laboratories, whereas measurement of the prothrombin time is reproducible and nearly always available. In a recent analysis of data we showed that a peak prothrombin time of >100 seconds provided prognostic information in patients with paracetamol induced fulminant hepatic failure, though supplementary information (that is, serum creatinine concentration and grade of coma) was required to identify patients who had a particularly poor outcome.7
The urgency to define the likely outcome as early as possible after the overdose has been increased by the availability of liver transplantation, which is increasingly utilised in patients with fulminant hepatic failure of other aetiologies.8'-2 In this study we reviewed a series of 150 consecutive patients with paracetamol induced fulminant hepatic failure to investigate whether changes in the daily prothrombin time complemented the peak prothrombin time in identifying a high risk group who would benefit from liver transplantation.
Patients and methods
In all, 150 patients with paracetamol induced fulminant hepatic failure were treated in the liver failure unit between October 1986 and February 1989. All of them met the criteria of Trey and Davidson for the diagnosis of fulminant hepatic failure.'3 Most patients
